You are here

  • Home
  • Archive
  • Volume 15, Issue 1
  • Immunotherapy in stage IV non-small cell lung cancer in a patient with Grave’s disease: safety and biomarkers of response

Article info

Article menu
Download PDFPDF
Case report
Immunotherapy in stage IV non-small cell lung cancer in a patient with Grave’s disease: safety and biomarkers of response

Authors

  1. Correspondence to Dr Marta Vilaça; martamvilaca{at}gmail.com
View Full Text

Citation

Vilaça M, Silva C, Estevinho F, et al
Immunotherapy in stage IV non-small cell lung cancer in a patient with Grave’s disease: safety and biomarkers of response
BMJ Case Reports CP 2022;15:e245632.

Publication history

  • Accepted December 23, 2021
  • First published January 17, 2022.
Online issue publication 
January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.